New late-breaking data at ADA underscore significant benefits of Abbott's FreeStyle Libre system for people living with diabetes

Abbott recently announced that expanded real-world evidence from more than 250,000 individuals using FreeStyle Libre system showed higher frequency scanning is associated with improved glucose control, decreased glucose variability and reduced incidence of both daytime and nocturnal hypoglycemia.


Editor's Note: This article originally appeared on Abbott's website.

ORLANDO, Fla., June 25, 2018 /PRNewswire/ -- Abbott today announced results from multiple new clinical and real-world studies that provide a comprehensive look at the global use of the FreeStyle Libre system, the company's revolutionary continuous glucose monitor (CGM), and its impact on health outcomes across various patient populations and countries. These data were presented as part of multiple late-breaking abstracts at the American Diabetes Association (ADA) 78th Scientific Sessions in Orlando, Fla. Click here to continue>>

News from our partners

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars